Effect of Rosuvastatin on Diastolic Dysfunction in Aortic Stenosis
Author Information
Author(s): Jassal Davinder S, Bhagirath Kapil M, Karlstedt Erin, Zeglinski Matthew, Dumesnil Jean G, Teo Koon K, Tam James W, Chan Kwan L
Primary Institution: St. Boniface General Hospital, Winnipeg, Manitoba, Canada
Hypothesis
Does treatment with rosuvastatin improve diastolic abnormalities in patients with aortic stenosis?
Conclusion
Rosuvastatin did not prevent the progression of diastolic dysfunction in patients with mild to moderate aortic stenosis.
Supporting Evidence
- Increased diastolic dysfunction was observed from baseline to follow-up in both treatment groups.
- Treatment with rosuvastatin did not show a significant difference in the progression of diastolic dysfunction compared to placebo.
- Patients were categorized into three groups based on the severity of aortic stenosis.
Takeaway
The study looked at whether a cholesterol medicine called rosuvastatin could help people with a heart problem called aortic stenosis. It found that the medicine didn't help their heart function get better over time.
Methodology
Patients were assessed using echocardiography to measure diastolic function and were followed for 3.5 years.
Potential Biases
The observational nature of the study may introduce bias in the results.
Limitations
The study was a subanalysis with a smaller sample size and may not be generalizable to other populations.
Participant Demographics
Patients aged 18 to 82 years with mild to moderate aortic stenosis, predominantly Caucasian.
Statistical Information
P-Value
p=0.43
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website